Remove topic clinical-trial-materials
article thumbnail

The Promise of Generative AI in Mitigating Bias in Continuing Medical Education

PM360

Continuing medical education (CME) is a top priority for healthcare providers in order to maintain their medical licensure, broaden and update their clinical knowledge, hone their skills, feed their curiosity, and ensure patients receive the best care and outcomes. The traditional development of CME materials is almost all done by humans.

Education 105
article thumbnail

Samsung Biologics, GreenLight conclude Covid-19 vaccine engineering run

Pharmaceutical Technology

The RNA platform of Samsung Biologics permitted GreenLight to move from mRNA vaccine conceptualisation to the delivery of released clinical trial material in under two years. Following the demonstration at Samsung, the clinical trial of GreenLight’s Covid-19 booster vaccine is anticipated to commence this year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Importance of Semantic Search Capabilities for Life Sciences Orgs

Copyright Clearance Center

Where it comes into play To eliminate the noise and provide relevant search results, information solutions must go beyond simple keyword matching and to use search engines and algorithms that link concepts, topics, and associations to form a deeper understanding of a user’s intent.

article thumbnail

Poseida and Roche to develop cell therapies for hematologic cancers

Pharmaceutical Technology

P-BCMA-ALLO1 is currently being analysed in a Phase I clinical trial while an investigational new drug (IND) application for P-CD19CD20-ALLO1 is anticipated next year. Furthermore, Roche will oversee the late-stage clinical development and worldwide marketing of all products under the alliance.

Sales 59
article thumbnail

RVAC Medicines, A*STAR partner for mRNA manufacturing expertise

Pharmaceutical Technology

This will aid in the production of new raw materials and possible clinical-grade assets to develop mRNA vaccines and therapies for infectious diseases, as well as other ailments with unmet needs. It commenced a first-in-human clinical trial of the vaccines in September this year. .

article thumbnail

HCP Engagement & Education

PM360

According to a recent survey, 95% of physicians say they are interested in learning about clinical trials and new treatments, but 68% said they feel overwhelmed by the amount of information necessary for them to stay current. Materials that allow efficient communication between physicians and patients are on the rise.

article thumbnail

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

Saphnelo is also being studied in a Phase III trial in lupus nephritis, where a person’s immune system targets the kidneys, eventually leading to kidney failure. Several other investigational therapies are expected to have material updates in 2023. Cell & Gene Therapy coverage on Clinical Trials Arena is supported by Cytiva.